Cargando…

Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study

OBJECTIVE: Systemic lupus erythematosus (SLE) disproportionately affects women and often develops during their reproductive years. Research suggests that some women who receive cyclophosphamide as treatment for SLE experience earlier decline in menstrual function, but reproductive health among women...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knight, Jessica H, Howards, Penelope P, Spencer, Jessica B, Tsagaris, Katina C, Lim, Sam S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Reproductive health and APS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051470/ https://www.ncbi.nlm.nih.gov/pubmed/27752335 http://dx.doi.org/10.1136/lupus-2015-000139

Ejemplares similares

Anti-Müllerian hormone in African-American women with systemic lupus erythematosus
por: Angley, Meghan, et al.
Publicado: (2020)

Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus
por: Lin, Pin, et al.
Publicado: (2014)

Pregnancy outcomes among African–American patients with systemic lupus erythematosus compared with controls
por: Barnado, April, et al.
Publicado: (2014)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies
por: Marder, Wendy, et al.
Publicado: (2016)

Effectiveness of a multidisciplinary clinical pathway for women with systemic lupus erythematosus and/or antiphospholipid syndrome
por: Wind, Merlijn, et al.
Publicado: (2021)

Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies
por: Marder, Wendy, et al.
Publicado: (2014)

Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
por: Balevic, Stephen J, et al.
Publicado: (2022)

Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data
por: Clowse, Megan E B, et al.
Publicado: (2022)

Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss
por: Mankee, Anil, et al.
Publicado: (2015)

Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials
por: Adelhelm, Josefine B H, et al.
Publicado: (2023)

Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)
por: Erton, Zeynep Belce, et al.
Publicado: (2022)

Breastfeeding in women with rheumatic diseases
por: Ikram, Naira, et al.
Publicado: (2021)

Recommendations for rapid sequence induction in Europe – How standardized is the standard of care?
por: Wetsch, Wolfgang, et al.
Publicado: (2013)

Knowledge and use of lactational amenorrhoea as a family planning method among adolescent mothers in Uganda: a secondary analysis of Demographic and Health Surveys between 2006 and 2016
por: Birabwa, Catherine, et al.
Publicado: (2022)

SAT-211 Gonadotrophin Rise Following Kisspeptin Analogue (MVT-602) Is Increased In Women With Hypothalamic Amenorrhoea Compared To Healthy Women
por: Eng, Pei Chia, et al.
Publicado: (2019)

Poor sleep and high anxiety levels in women with functional hypothalamic amenorrhoea: A wake-up call for physicians?
por: Tranoulis, Anastasios, et al.
Publicado: (2019)

Atypical Findings of Focal Nodular Hyperplasia with Gadoxetic Acid (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging
por: Yoon, Jung-Hee, et al.
Publicado: (2014)

Estado actual de los tratamientos para la COVID-19
por: Llover, Mariona Nadal, et al.
Publicado: (2021)

Mantenimiento de tratamientos crónicos en pacientes afectados de COVID-19
por: Sánchez, Jesús M. Redondo, et al.
Publicado: (2021)

Apparent Amenorrhœa
Publicado: (1909)

Pigmentation in Amenorrhœa
por: Lawrence, A. E. Aust
Publicado: (1894)

Observations on Amenorrhœa
por: Mahon, J.
Publicado: (1818)

Anæmia with Amenorrhœa
Publicado: (1890)

Treatment of Amenorrhœa
Publicado: (1891)

Secondary amenorrhoea due to pheochromocytoma: a case report
por: Wakil, Ammar, et al.
Publicado: (2008)

Is prevention of systemic lupus erythematosus a goal?
por: Olsen, Nancy J, et al.
Publicado: (2014)

Prognosis in Primary Amenorrhœa
Publicado: (1901)

Cypripedium in Amenorrhœa and Dysmenorrhœa
por: Batte, G. H.
Publicado: (1876)

Amenorrhœa of School Girls
Publicado: (1892)

Amenorrhœa in School Girls
Publicado: (1892)

Potassium Permanganate in Amenorrhœa
por: Marshall, Benjamin
Publicado: (1886)

Potassium Permanganate in Amenorrhœa
Publicado: (1887)

Permanganate of Potassium in Amenorrhœa
por: Doering, Edmund J.
Publicado: (1885)

The Surgical Treatment of Amenorrhœa
por: Storer, Horatio R.
Publicado: (1864)

2122: Factors associated with unintended pregnancy in cancer survivors after cancer
por: Shandley, Lisa M., et al.
Publicado: (2018)

Virilization Secondary to an Ovarian Leydig Cell Tumor
por: Symczyk, Oksana, et al.
Publicado: (2021)

On the Use of the Senecios in Functional Amenorrhœa
por: Fothergill, W. E.
Publicado: (1898)

Current understanding of hypothalamic amenorrhoea
por: Roberts, Rachel E., et al.
Publicado: (2020)

On the Employment of Apiol in Amenorrhœa and Dysmenorrhœa
por: Corlieu,
Publicado: (1866)

Cannot write session to /tmp/vufind_sessions/sess_itbh1jo5plt29dkde7uu4ru8r4